Canine Melanoma Cell Line (CMGD-2) from KERAFAST, INC.

Search, find, compare suppliers for Canine Melanoma Cell Line (CMGD-2) products.

Edit
Product Name	Canine Melanoma Cell Line (CMGD-2)
Description	Source: Oral tumor (malignant melanoma). Cell type: Melanoma.
Size	1 vial
Concentration	n/a
Applications	n/a
Other Names	n/a
Gene, Accession, CAS #	Accession: CVCL_0D66
Catalog #	EMN006-FP
Price	$605
Order / More Info	Canine Melanoma Cell Line (CMGD-2) from KERAFAST, INC.
Product Specific References	Bianco SR, Sun J, Fosmire SP, Hance K, Padilla ML, Ritt MG, Getzy DM, Duke RC, Withrow SJ, Lana S, Matthiesen DT, Dow SW, Bellgrau D, Cutter GR, Helfand SC, Modiano JF. Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Ther. 2003 Sep;10(9):726-36. Milner RJ, Salute M, Crawford C, Abbot JR, Farese J. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine. Vet Immunol Immunopathol. 2006 Dec 15;114(3-4):273-84. Epub 2006 Oct 5. Igase M, Hwang CC, Coffey M, Okuda M, Noguchi S, Mizuno T. The oncolytic effects of reovirus in canine solid tumor cell lines. J Vet Med Sci. 2015 Jun 1;77(5):541-8. doi: 10.1292/jvms.14-0570. Epub 2015 Jan 16. Enjoji S, Yabe R, Fujiwara N, Tsuji S, Vitek MP, Mizuno T, Nakagawa T, Usui T, Ohama T, Sato K. The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma. J Vet Med Sci. 2015 Jun 11. Lin W, Modiano JF, Ito D. Stage-specific embryonic antigen: determiningexpression in canine glioblastoma, melanoma, and mammary cancer cells. J Vet Sci.2017 Mar 30;18(1):101-104. doi: 10.4142/jvs.2017.18.1.101. PubMed PMID: 27456773;PubMed Central PMCID: PMC5366293.

KERAFAST, INC.

KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826

info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com

https://www.kerafast.com

Profile of KERAFAST, INC.